HomepageMedicinePharma Pulse 2/7/25: SCOPE Summit 2025 Coverage, Genetic Sensitivity to Stress Possibly Links to Lung Cancer & more Medicine Pharma Pulse 2/7/25: SCOPE Summit 2025 Coverage, Genetic Sensitivity to Stress Possibly Links to Lung Cancer & more admin Posted on February 10, 2025 The latest news for pharma industry insiders. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostSignature Global Q3 results: Signature Global trims net debt 29% to ₹720 crore on strong sales, internal cash flows Next PostVice premier stresses all-out rescue efforts in SW China's landslide You Might Also Like Medicine Women’s Healthcare: Will Changing Laws Inhibit Latest Innovations in Fertility and Birth Control Treatments? admin July 31, 2024 Medicine FDA’s Oncologic Drugs Advisory Committee Recommends Earlier Treatment with Carvykti for Relapsed or Refractory Multiple Myeloma admin March 19, 2024 Medicine Pharmaceutical Executive: February 2025 Issue (PDF) admin February 17, 2025 Medicine FDA Approves New Herceptin Biosimilar for the Treatment of Multiple HER2-Overexpressing Cancers admin April 30, 2024
Medicine Women’s Healthcare: Will Changing Laws Inhibit Latest Innovations in Fertility and Birth Control Treatments? admin July 31, 2024
Medicine FDA’s Oncologic Drugs Advisory Committee Recommends Earlier Treatment with Carvykti for Relapsed or Refractory Multiple Myeloma admin March 19, 2024
Medicine FDA Approves New Herceptin Biosimilar for the Treatment of Multiple HER2-Overexpressing Cancers admin April 30, 2024